Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor.
about
EGFR Signaling in Liver DiseasesCellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosisCholangiocarcinoma: molecular pathways and therapeutic opportunitiesTranslational horizons in the tumor microenvironment: harnessing breakthroughs and targeting cures.Hepatitis B virus X induces inflammation and cancer in mice liver through dysregulation of cytoskeletal remodeling and lipid metabolism.Desmoplastic stroma and cholangiocarcinoma: clinical implications and therapeutic targeting.Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma.Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness.Transforming Growth Factors α and β Are Essential for Modeling Cholangiocarcinoma Desmoplasia and Progression in a Three-Dimensional Organotypic Culture Model.Molecular mechanisms driving cholangiocarcinoma invasiveness: an overview.Extracellular vesicles as therapeutic carriers of microRNAs for cholangiocarcinoma.The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer.Understanding liver regeneration to bring new insights to the mechanisms driving cholangiocarcinoma.Blocking of the EGFR-STAT3 signaling pathway through afatinib treatment inhibited the intrahepatic cholangiocarcinoma.The Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor Epithelium
P2860
Q26771265-F6DF6827-A1B4-4191-B4AA-D3E034FAC5DBQ27021577-870ED759-FCE5-49A3-AC80-9986A855AB8BQ34959174-0B3E3C1E-076D-42D5-A79E-EB42585D97B4Q35219539-52BDB545-B301-4BAE-A76E-22FB9811D5BAQ37688574-9EF96100-1AF4-4717-997D-095194DC89DEQ38152382-43E9138C-A526-4877-825B-48F4CADB7D77Q38720813-C200D025-E26F-473B-A4F7-72187317F380Q38812588-6DB18B2E-E57D-4D85-8159-538A55E04D90Q42371988-B1FCB1E8-B4F2-4AD5-9610-326CC43483DEQ45055057-6CF6843D-B385-4CD2-9398-BE66DA953DB3Q47603972-6524EAF9-3FAB-48A4-8052-90596099ECB3Q49237863-1AE1258A-CCCD-4A4A-8C6A-2460D371F1B2Q50350640-53FEDD21-64E3-41DB-B747-825873A4E0E5Q52729640-3695BC1E-2956-4423-8941-0F60B687E049Q55364953-AEAFEE41-53D0-4413-852B-323A91B696DAQ59133892-2CD3332A-B9E1-4B5F-9ABE-69A877BBFFD5
P2860
Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Hepatic myofibroblasts promote ...... dermal growth factor receptor.
@en
Hepatic myofibroblasts promote ...... dermal growth factor receptor.
@nl
type
label
Hepatic myofibroblasts promote ...... dermal growth factor receptor.
@en
Hepatic myofibroblasts promote ...... dermal growth factor receptor.
@nl
prefLabel
Hepatic myofibroblasts promote ...... dermal growth factor receptor.
@en
Hepatic myofibroblasts promote ...... dermal growth factor receptor.
@nl
P2093
P2860
P356
P1433
P1476
Hepatic myofibroblasts promote ...... idermal growth factor receptor
@en
P2093
Audrey Clapéron
Aurélie Prignon
Chantal Housset
Delphine Firrincieli
Dominique Wendum
Fatiha Merabtene
Filomena Conti
Lynda Aoudjehane
Martine Mergey
Olivier Scatton
P2860
P304
P356
10.1002/HEP.26585
P407
P577
2013-10-25T00:00:00Z